DrugPatentWatch Database Preview

Losartan potassium - Generic Drug Details

« Back to Dashboard

What are the generic sources for losartan potassium and what is the scope of patent protection?

Losartan potassium is the generic ingredient in two branded drugs marketed by Organon, Alembic Pharms Ltd, Apotex Corp, Aurobindo Pharma, Cadista Pharms, Hetero Labs Ltd V, Hikma, Hisun Pharm Hangzhou, Ipca Labs Ltd, Lupin Ltd, Macleods Pharms Ltd, Micro Labs, Mylan, Prinston Inc, Sandoz, Strides Pharma, Teva, Torrent Pharms, Unichem, Upsher Smith Labs, Watson Labs, and Zydus Pharms Usa Inc, and is included in twenty-two NDAs. Additional information is available in the individual branded drug profile pages.

There are thirty-nine drug master file entries for losartan potassium. Fifty-one suppliers are listed for this compound.

Summary for losartan potassium

US Patents:	0
Tradenames:	2
Applicants:	22
NDAs:	22
Drug Master File Entries:	39
Suppliers / Packagers:	51
Bulk Api Vendors:	222
Clinical Trials:	64
Patent Applications:	4,849
Formulation / Manufacturing:	see details
Drug Prices:	Drug price trends for losartan potassium
Drug Sales Revenues:	Drug sales revenues for losartan potassium
What excipients (inactive ingredients) are in losartan potassium?	losartan potassium excipients list
DailyMed Link:	losartan potassium at DailyMed

See drug prices for losartan potassium

See drug sales revenues for losartan potassium

Recent Clinical Trials for losartan potassium

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Anna Stanhewicz, PhD	Early Phase 1
Oregon Health and Science University	Phase 2
OHSU Knight Cancer Institute	Phase 2

See all losartan potassium clinical trials

Pharmacology for losartan potassium

Drug Class	Angiotensin 2 Receptor Blocker
Mechanism of Action	Angiotensin 2 Receptor Antagonists

Medical Subject Heading (MeSH) Categories for losartan potassium

Angiotensin II Type 1 Receptor Blockers

Anti-Arrhythmia Agents

Antihypertensive Agents

Paragraph IV (Patent) Challenges for LOSARTAN POTASSIUM

Tradename	Dosage	Ingredient	NDA	Submissiondate
COZAAR	TABLET;ORAL	losartan potassium	020386

US Patents and Regulatory Information for losartan potassium

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Upsher Smith Labs	LOSARTAN POTASSIUM	losartan potassium	TABLET;ORAL	090544-003	Oct 6, 2010	AB	RX	No	No
Apotex Corp	LOSARTAN POTASSIUM	losartan potassium	TABLET;ORAL	090790-001	Oct 6, 2010		DISCN	No	No
Torrent Pharms	LOSARTAN POTASSIUM	losartan potassium	TABLET;ORAL	090467-002	Oct 6, 2010		DISCN	No	No
Strides Pharma	LOSARTAN POTASSIUM	losartan potassium	TABLET;ORAL	090382-003	Oct 6, 2010	AB	RX	No	No
Zydus Pharms Usa Inc	LOSARTAN POTASSIUM	losartan potassium	TABLET;ORAL	078243-003	Oct 6, 2010	AB	RX	No	No
Hikma	LOSARTAN POTASSIUM	losartan potassium	TABLET;ORAL	077459-003	Oct 6, 2010		DISCN	No	No
Micro Labs	LOSARTAN POTASSIUM	losartan potassium	TABLET;ORAL	091541-003	Sep 24, 2012	AB	RX	No	No

Expired US Patents for losartan potassium

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Organon	COZAAR	losartan potassium	TABLET;ORAL	020386-001	Apr 14, 1995
Organon	COZAAR	losartan potassium	TABLET;ORAL	020386-003	Oct 13, 1998
Organon	COZAAR	losartan potassium	TABLET;ORAL	020386-002	Apr 14, 1995
Organon	COZAAR	losartan potassium	TABLET;ORAL	020386-001	Apr 14, 1995
Organon	COZAAR	losartan potassium	TABLET;ORAL	020386-003	Oct 13, 1998
Organon	COZAAR	losartan potassium	TABLET;ORAL	020386-002	Apr 14, 1995
Organon	COZAAR	losartan potassium	TABLET;ORAL	020386-003	Oct 13, 1998